Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VRSN✓SelectedUSD · VRSNGSK vs VRSN performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs VRSN

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.3%
VRSN return
+25.0%
Excess return
-17.7%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioVRSNExcessAlpha
1D-0.1%+0.1%-0.3%-0.1%
7D-5.3%-1.7%-3.6%-5.3%
30D-3.7%+0.1%-3.8%-3.6%
3M-7.3%+11.1%-18.4%-7.2%
6M-4.2%+1.8%-6.1%-4.2%
YTD+0.9%+27.8%-27.0%+0.6%
1Y+7.3%+25.0%-17.7%+8.3%
All+7.3%+25.0%-17.7%+8.3%

Cumulative growth

Daily Returns

Daily percentage return beside VRSN.

Daily Out/Under-Performance

Portfolio return minus VRSN return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VRSN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded VRSN wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling